Shield Therapeutics PLC (LSE:STX) - Share price - Overview

Stock Report

Shield Therapeutics PLC STX

Last Price
GBX26.50

Day Change
-1.00|-3.64%

As of 20/02/2018
08:14:15 GMT | GBX
Minimum 15 Minutes Delay.

Last Close27.50p
Day Range27.00 - 27.00
Mkt Cap32.02Mil
52-Wk Range27.00 - 170.00
Yield %-
ISINGB00BYV81293
Volume1,000
P/E-1.77
P/S1.36
P/CF-1.94

Share Price

Financials
201420152016
More ...
Income Statement
Revenue--0.30
Operating Income-3.39-6.43-12.46
Net Income-12.91-23.63-15.02
Basic EPS-0.12-0.22-0.15
Avg. Diluted Shares Outstanding108108101
Balance Sheet
Current Assets0.562.3323.38
Non Current Assets0.450.5329.00
Total Assets1.002.8652.38
Current Liabilities9.003.583.99
Total Liabilities21.0321.503.99
Total Equity-20.03-18.6448.40
Cash Flow
Operating Cash Flow-3.34-4.18-10.26
Capital Expenditure-0.09-0.13-3.18
Free Cash Flow-3.43-4.32-13.43

In millions, except "Basic EPS". Currency is GBP.

Company Profile

Shield Therapeutics PLC is focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals. It is a specialty pharmaceutical company.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Fiscal Year Ends

December

Employees

40
Key Stats
More ...
Price/Earning TTM-1.83
Price/Book0.63
Price/Sales TTM144.74
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % TTM-4,098.68
Net Margin % TTM-4,939.47
ROE TTM-100.94
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.